TrivarX LimitedASX: TRI

New AI Tool Expands Patient Reach and Market Opportunities

· Issued by TrivarX Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

The newly developed algorithm utilizes heart rate and heart rate variability to accurately screen for Major Depressive Episode using a single lead ECG. Initial testing on a subset of subjects has shown promising performance metrics, indicating high sensitivity and specificity for the screening tool. The company plans to pursue further clinical trials and licensing opportunities to enhance the algorithm's application in various markets.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

TrivarX Limited on 6ix

Earlier from TrivarX

Later from TrivarX

All TrivarX news releases